<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39603702</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1756-1833</ISSN><JournalIssue CitedMedium="Internet"><Volume>387</Volume><PubDate><Year>2024</Year><Month>Nov</Month><Day>27</Day></PubDate></JournalIssue><Title>BMJ (Clinical research ed.)</Title><ISOAbbreviation>BMJ</ISOAbbreviation></Journal><ArticleTitle>Interventions for the management of long covid (post-covid condition): living systematic review.</ArticleTitle><Pagination><StartPage>e081318</StartPage><MedlinePgn>e081318</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e081318</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmj-2024-081318</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the effectiveness of interventions for the management of long covid (post-covid condition).</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Living systematic review.</AbstractText><AbstractText Label="DATA SOURCES" NlmCategory="METHODS">Medline, Embase, CINAHL, PsycInfo, Allied and Complementary Medicine Database, and Cochrane Central Register of Controlled Trials from inception to December 2023.</AbstractText><AbstractText Label="ELIGIBILITY CRITERIA" NlmCategory="METHODS">Trials that randomised adults (&#x2265;18 years) with long covid to drug or non-drug interventions, placebo or sham, or usual care.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">24 trials with 3695 patients were eligible. Four trials (n=708 patients) investigated drug interventions, eight (n=985) physical activity or rehabilitation, three (n=314) behavioural, four (n=794) dietary, four (n=309) medical devices and technologies, and one (n=585) a combination of physical exercise and mental health rehabilitation. Moderate certainty evidence suggested that, compared with usual care, an online programme of cognitive behavioural therapy (CBT) probably reduces fatigue (mean difference -8.4, 95% confidence interval (CI) -13.11 to -3.69; Checklist for Individual Strength fatigue subscale; range 8-56, higher scores indicate greater impairment) and probably improves concentration (mean difference -5.2, -7.97 to -2.43; Checklist for Individual Strength concentration problems subscale; range 4-28; higher scores indicate greater impairment). Moderate certainty evidence suggested that, compared with usual care, an online, supervised, combined physical and mental health rehabilitation programme probably leads to improvement in overall health, with an estimated 161 more patients per 1000 (95% CI 61 more to 292 more) experiencing meaningful improvement or recovery, probably reduces symptoms of depression (mean difference -1.50, -2.41 to -0.59; Hospital Anxiety and Depression Scale depression subscale; range 0-21; higher scores indicate greater impairment), and probably improves quality of life (0.04, 95% CI 0.00 to 0.08; Patient-Reported Outcomes Measurement Information System 29+2 Profile; range -0.022-1; higher scores indicate less impairment). Moderate certainty evidence suggested that intermittent aerobic exercise 3-5 times weekly for 4-6 weeks probably improves physical function compared with continuous exercise (mean difference 3.8, 1.12 to 6.48; SF-36 physical component summary score; range 0-100; higher scores indicate less impairment). No compelling evidence was found to support the effectiveness of other interventions, including, among others, vortioxetine, leronlimab, combined probiotics-prebiotics, coenzyme Q10, amygdala and insula retraining, combined L-arginine and vitamin C, inspiratory muscle training, transcranial direct current stimulation, hyperbaric oxygen, a mobile application providing education on long covid.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Moderate certainty evidence suggests that CBT and physical and mental health rehabilitation probably improve symptoms of long covid.</AbstractText><AbstractText Label="SYSTEMATIC REVIEW REGISTRATION" NlmCategory="BACKGROUND">Open Science Framework https://osf.io/9h7zm/.</AbstractText><AbstractText Label="READERS' NOTE" NlmCategory="UNASSIGNED">This article is a living systematic review that will be updated to reflect emerging evidence. Updates may occur for up to two years from the date of original publication.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeraatkar</LastName><ForeName>Dena</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-4287-0541</Identifier><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, ON, Canada zeraatd@mcmaster.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ling</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirsh</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jassal</LastName><ForeName>Tanvir</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahab</LastName><ForeName>Mahnoor</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Movahed</LastName><ForeName>Hamed</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talukdar</LastName><ForeName>Jhalok Ronjan</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walch</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakraborty</LastName><ForeName>Samantha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turner</LastName><ForeName>Tari</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turkstra</LastName><ForeName>Lyn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Rehabilitation Science and Program in Neuroscience, McMaster University, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIntyre</LastName><ForeName>Roger S</ForeName><Initials>RS</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izcovich</LastName><ForeName>Ariel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Universidad del Salvador, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mbuagbaw</LastName><ForeName>Lawrence</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agoritsas</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division General Internal Medicine, Department of Medicine, University Hospitals of Geneva, Geneva, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The MAGIC Evidence Ecosystem Foundation, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Flottorp</LastName><ForeName>Signe A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Centre for Epidemic Interventions Research, Norwegian Institute of Public Health, Oslo, Norway.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garner</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pitre</LastName><ForeName>Tyler</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Respirology, Department of Medicine, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couban</LastName><ForeName>Rachel J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busse</LastName><ForeName>Jason W</ForeName><Initials>JW</Initials><AffiliationInfo><Affiliation>Department of Anesthesia, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ</MedlineTA><NlmUniqueID>8900488</NlmUniqueID><ISSNLinking>0959-8138</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000534" MajorTopicYN="N">rehabilitation</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015928" MajorTopicYN="N">Cognitive Behavioral Therapy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015444" MajorTopicYN="N">Exercise</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/disclosure-of-interest/ and declare: support from the Long COVID Web and the Canadian Institutes of Health Research for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>11</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39603702</ArticleId><ArticleId IdType="doi">10.1136/bmj-2024-081318</ArticleId><ArticleId IdType="pmc">PMC11600537</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Panneer S, Kantamaneni K, Palaniswamy U, et al. . Health, Economic and Social Development Challenges of the COVID-19 Pandemic: Strategies for Multiple and Interconnected Issues. Healthcare (Basel) 2022;10:770. 10.3390/healthcare10050770&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare10050770</ArticleId><ArticleId IdType="pmc">PMC9140679</ArticleId><ArticleId IdType="pubmed">35627910</ArticleId></ArticleIdList></Reference><Reference><Citation>Delardas O, Kechagias KS, Pontikos PN, Giannos P. Socio-Economic Impacts and Challenges of the Coronavirus Pandemic (COVID-19): An Updated Review. Sustainability 2022;14:9699 10.3390/su14159699 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/su14159699</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis 2022;226:1593-607. 10.1093/infdis/jiac136&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open 2021;4:e2111417. 10.1001/jamanetworkopen.2021.11417&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Lunz Trujillo K, Safarpour A, et al. . Association of Post-COVID-19 Condition Symptoms and Employment Status. JAMA Netw Open 2023;6:e2256152. 10.1001/jamanetworkopen.2022.56152&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.56152</ArticleId><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Wulf Hanson S, Abbafati C, Aerts JG, et al. Global Burden of Disease Long COVID Collaborators . Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA 2022;328:1604-15. 10.1001/jama.2022.18931&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group . Persistent Symptoms in Patients After Acute COVID-19. JAMA 2020;324:603-5. 10.1001/jama.2020.12603&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. . Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect 2021;27:89-95. 10.1016/j.cmi.2020.09.023&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz YMJ, Van Herck M, Delbressine JM, et al. . Persistent symptoms 3&#x2005;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020;6:00542-2020. 10.1183/23120541.00542-2020&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00542-2020</ArticleId><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Alcoba G, et al. COVICARE TEAM . COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings. Ann Intern Med 2021;174:723-5. 10.7326/M20-5926&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-5926</ArticleId><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al. . Prevalence and Correlates of Long COVID Symptoms Among US Adults. JAMA Netw Open 2022;5:e2238804. 10.1001/jamanetworkopen.2022.38804&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, et al. . Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 2022;101:93-135. 10.1016/j.bbi.2021.12.020&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslam A, Prasad V. Comparability of Control and Comparison Groups in Studies Assessing Long COVID. Am J Med 2023;S0002-9343(23)00038-4. 10.1016/j.amjmed.2023.01.005&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.01.005</ArticleId><ArticleId IdType="pmc">PMC9912142</ArticleId><ArticleId IdType="pubmed">36708796</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracy Beth H, Shamez L, Vinay P. How methodological pitfalls have created widespread misunderstanding about long COVID. BMJ Evid Based Med 2023:bmjebm-2023-112338.</Citation></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, et al. . The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine 2022;55:101762. 10.1016/j.eclinm.2022.101762&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Jassat W, Reyes LF, Munblit D, et al. . Long COVID in low-income and middle-income countries: the hidden public health crisis. Lancet 2023;402:1115-7. 10.1016/S0140-6736(23)01685-9&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)01685-9</ArticleId><ArticleId IdType="pubmed">37652071</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Khan MA, Putrino D, Woodcock A, Kell DB, Pretorius E. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends Endocrinol Metab 2023;34:321-44. 10.1016/j.tem.2023.03.002&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese JT, Blau H, Casiraghi E, et al. N3C Consortium. RECOVER Consortium . Generalisable long COVID subtypes: findings from the NIH N3C and RECOVER programmes. EBioMedicine 2023;87:104413. 10.1016/j.ebiom.2022.104413&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, et al. . Prognostic Factors for Post-COVID-19 Syndrome: A Systematic Review and Meta-Analysis. J Clin Med 2022;11:1541. 10.3390/jcm11061541&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11061541</ArticleId><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, et al. . Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J Clin Med 2022;11:7314. 10.3390/jcm11247314&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, et al. . Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 Conditions. JAMA Psychiatry 2022;79:1081-91. 10.1001/jamapsychiatry.2022.2640&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.2640</ArticleId><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, et al. Sant&#xe9;, Pratiques, Relations et In&#xe9;galit&#xe9;s Sociales en Population G&#xe9;n&#xe9;rale Pendant la Crise COVID-19&#x2013;S&#xe9;rologie (SAPRIS-SERO) Study Group . Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 Pandemic. JAMA Intern Med 2022;182:19-25. 10.1001/jamainternmed.2021.6454&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102-7. 10.1016/S1473-3099(21)00703-9&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C, Zocchi C, Tassetti L, et al. AOU Careggi COVID-19 Follow-up study Group . Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study. Eur J Intern Med 2022;97:36-41. 10.1016/j.ejim.2021.11.018&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="pubmed">34903448</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M, Xie Y, Topol EJ, Al-Aly Z. Three-year outcomes of post-acute sequelae of COVID-19. Nat Med 2024;30:1564-73. 10.1038/s41591-024-02987-8&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-024-02987-8</ArticleId><ArticleId IdType="pmc">PMC11186764</ArticleId><ArticleId IdType="pubmed">38816608</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, et al. . Characterising long COVID: a living systematic review. BMJ Glob Health 2021;6:e005427. 10.1136/bmjgh-2021-005427&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Subbaraman N. US health agency will invest $1 billion to investigate &#x2018;long COVID&#x2019;. Nature 2021;591:356. 10.1038/d41586-021-00586-y&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00586-y</ArticleId><ArticleId IdType="pubmed">33664445</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen KS, Mogensen TH, Agergaard J, et al. . High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. Lancet Reg Health Eur 2023;24:100539. 10.1016/j.lanepe.2022.100539&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2022.100539</ArticleId><ArticleId IdType="pmc">PMC9627534</ArticleId><ArticleId IdType="pubmed">36337437</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer LH, Hendry A, Makanjuola A, et al. . What interventions or best practice are there to support people with Long COVID, or similar post-viral conditions or conditions characterised by fatigue, to return to normal activities: a rapid review. medRxiv. 2023:2023.01.24.23284947 10.1101/2023.01.24.23284947</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.01.24.23284947</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N, Bonica R, Cotugno S, et al. . Interventions for Improving Long COVID-19 Symptomatology: A Systematic Review. Viruses 2022;14:1863. 10.3390/v14091863&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14091863</ArticleId><ArticleId IdType="pmc">PMC9502379</ArticleId><ArticleId IdType="pubmed">36146672</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramante CT, Buse JB, Liebovitz DM, et al. COVID-OUT Study Team . Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis 2023;23:1119-29. 10.1016/S1473-3099(23)00299-2&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00299-2</ArticleId><ArticleId IdType="pmc">PMC11259948</ArticleId><ArticleId IdType="pubmed">37302406</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao Y-S, McGill SC, Gates M. Clinical classification and interventions for post-COVID-19 condition: a scoping review. Can J Health Technol 2022;2. 10.51731/cjht.2022.337</Citation><ArticleIdList><ArticleId IdType="doi">10.51731/cjht.2022.337</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee YJ, Fan BE, Young BE, Dalan R, Lye DC. Clinical trials on the pharmacological treatment of long COVID: A systematic review. J Med Virol 2023;95:e28289. 10.1002/jmv.28289&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28289</ArticleId><ArticleId IdType="pmc">PMC9878018</ArticleId><ArticleId IdType="pubmed">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Long-COVID treatments: why the world is still waiting. Nature 2022;608:258-60. 10.1038/d41586-022-02140-w&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-02140-w</ArticleId><ArticleId IdType="pubmed">35945375</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris E. Federal Government Announces Long COVID Trials, Research Office. JAMA 2023;330:797. 10.1001/jama.2023.13936&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.13936</ArticleId><ArticleId IdType="pubmed">37585213</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitre T, Cheng S, Cusano E, et al. . Methodology and design of platform trials: a meta-epidemiological study. J Clin Epidemiol 2023;157:1-12. 10.1016/j.jclinepi.2023.02.010&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2023.02.010</ArticleId><ArticleId IdType="pmc">PMC9991927</ArticleId><ArticleId IdType="pubmed">36893990</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies M. Long covid patients travel abroad for expensive and experimental &#x201c;blood washing&#x201d;. BMJ 2022;378:o1671. 10.1136/bmj.o1671&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.o1671</ArticleId><ArticleId IdType="pubmed">35820689</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladyzhets B. &#x2018;Underwhelming&#x2019;: NIH trials fail to test meaningful long Covid treatments &#x2014; after 2.5 years and $1 billion. Stat News, 2023.</Citation></Reference><Reference><Citation>Sellers F. Desperate covid long-haulers turn to costly, unproven treatments: Washington Post; 2022. https://www.washingtonpost.com/health/2022/11/25/long-covid-treatments-unproven-brain-fog/.</Citation></Reference><Reference><Citation>Belluck P. Paxlovid may reduce risk of long Covid in eligible patients, study finds. The New York Times. 7 Nov 2022. https://www.nytimes.com/2022/11/07/health/paxlovid-long-covid.html. [Accessed 19 Feb 2023.]</Citation></Reference><Reference><Citation>Califf DR. And preliminary epidemiological findings point to the distinct possibility of the bivalent vaccines and antivirals reducing risk of long covid. Twitter. 14 Nov 2022. https://twitter.com/DrCaliff_FDA/status/1592269459133431809?s=20. [Accessed 19 Feb 2023.]</Citation></Reference><Reference><Citation>Constantino KA. A new long Covid treatment shows promise, but insurance won&#x2019;t cover it and some doctors are skeptical: Here&#x2019;s why. CNBC, 2023. https://www.cnbc.com/2023/04/20/treating-long-covid-hyperbaric-oxygen-therapy-shows-promise-concerns.html.</Citation></Reference><Reference><Citation>Wilson C. Exercise programme helps people with long covid, but it&#x2019;s no panacea. 2024. https://www.newscientist.com/article/2416283-exercise-programme-helps-people-with-long-covid-but-its-no-panacea/.</Citation></Reference><Reference><Citation>Tuller D. Trial By Error: Dutch CBT Study for Long Covid Proves that Unblinded Studies with Subjective Outcomes Generate Positive Reports. Virology blog; 2023. https://virology.ws/2023/05/25/trial-by-error-dutch-cbt-study-for-long-covid-reports-proves-that-unblinded-studies-with-subjective-outcomes-produce-positive-results-as-predicted/.</Citation></Reference><Reference><Citation>Vink M, Vink-Niese A. Could Cognitive Behavioural Therapy Be an Effective Treatment for Long COVID and Post COVID-19 Fatigue Syndrome? Lessons from the Qure Study for Q-Fever Fatigue Syndrome. Healthcare (Basel) 2020;8:552. 10.3390/healthcare8040552&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8040552</ArticleId><ArticleId IdType="pmc">PMC7764131</ArticleId><ArticleId IdType="pubmed">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>Dena Z, Michael L, Sarah K, et al. . Interventions for the management of post COVID-19 condition (long COVID): Protocol for a living systematic review &amp;amp;amp; network meta-analysis. medRxiv 2024:2024.03.15.24304168.</Citation></Reference><Reference><Citation>National Academies of Sciences E . In: Fineberg HV, Brown L, Worku T, Goldowitz I, eds. Medicine. A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences. National Academies Press, 2024.</Citation><ArticleIdList><ArticleId IdType="pubmed">39110819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ely EW, Brown LM, Fineberg HV, National Academies of Sciences, Engineering, and Medicine Committee on Examining the Working Definition for Long Covid . Long Covid Defined. N Engl J Med 2024. . 10.1056/NEJMsb2408466&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb2408466</ArticleId><ArticleId IdType="pubmed">39083764</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeraatkar D, Pitre T, Leung G, et al. . Consistency of covid-19 trial preprints with published reports and impact for decision making: retrospective review. BMJ Med 2022;1:e000309. 10.1136/bmjmed-2022-000309&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000309</ArticleId><ArticleId IdType="pmc">PMC9951374</ArticleId><ArticleId IdType="pubmed">36936583</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson M, Evrenoglou T, Gra&#xf1;a C, Chaimani A, Boutron I. Comparison of effect estimates between preprints and peer-reviewed journal articles of COVID-19 trials. BMC Med Res Methodol 2024;24:9. 10.1186/s12874-023-02136-8&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-023-02136-8</ArticleId><ArticleId IdType="pmc">PMC10782611</ArticleId><ArticleId IdType="pubmed">38212714</ArticleId></ArticleIdList></Reference><Reference><Citation>Janda G, Khetpal V, Shi X, Ross JS, Wallach JD. Comparison of Clinical Study Results Reported in medRxiv Preprints vs Peer-reviewed Journal Articles. JAMA Netw Open 2022;5:e2245847. 10.1001/jamanetworkopen.2022.45847&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.45847</ArticleId><ArticleId IdType="pmc">PMC9856222</ArticleId><ArticleId IdType="pubmed">36484989</ArticleId></ArticleIdList></Reference><Reference><Citation>Weibel S, Popp M, Reis S, Skoetz N, Garner P, Sydenham E. Identifying and managing problematic trials: A research integrity assessment tool for randomized controlled trials in evidence synthesis. Res Synth Methods 2023;14:357-69. 10.1002/jrsm.1599&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1599</ArticleId><ArticleId IdType="pmc">PMC10551123</ArticleId><ArticleId IdType="pubmed">36054583</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, et al. RECOVER Consortium . Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA 2023;329:1934-46. 10.1001/jama.2023.8823&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2023.8823</ArticleId><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickersin K, Min YI. Publication bias: the problem that won&#x2019;t go away. Ann N Y Acad Sci 1993;703:135-46. 10.1111/j.1749-6632.1993.tb26343.x&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1993.tb26343.x</ArticleId><ArticleId IdType="pubmed">8192291</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdugo-Paiva F, Vergara C, &#xc1;vila C, et al. . COVID-19 Living Overview of Evidence repository is highly comprehensive and can be used as a single source for COVID-19 studies. J Clin Epidemiol 2022;149:195-202. 10.1016/j.jclinepi.2022.05.001&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2022.05.001</ArticleId><ArticleId IdType="pmc">PMC9116966</ArticleId><ArticleId IdType="pubmed">35597369</ArticleId></ArticleIdList></Reference><Reference><Citation>Raine GA, Khouja CL, Khatwa M, Harden M, Sutcliffe K, Sowden AJ. Treatment and rehabilitation of Long COVID: A scope of the literature. Update April 2023. Research Report. London: York; 2023.</Citation></Reference><Reference><Citation>Munblit D, Nicholson TR, Needham DM, et al. . Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development. BMC Med 2022;20:50. 10.1186/s12916-021-02222-y&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02222-y</ArticleId><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson T, Akrami A, et al. PC-COS project steering committee . A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir Med 2022;10:715-24. 10.1016/S2213-2600(22)00169-2&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagliati A, Strasser ZH, Hossein Abad ZS, et al. Consortium for Clinical Characterization of COVID-19 by EHR (4CE) Consortium for Clinical Characterization of COVID-19 by EHR (4CE) . Characterization of long COVID temporal sub-phenotypes by distributed representation learning from electronic health record data: a cohort study. EClinicalMedicine 2023;64:102210. 10.1016/j.eclinm.2023.102210&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.102210</ArticleId><ArticleId IdType="pmc">PMC10511779</ArticleId><ArticleId IdType="pubmed">37745021</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny G, McCann K, O&#x2019;Brien C, et al. All-Ireland Infectious Diseases (AIID) Cohort Study Group . Identification of Distinct Long COVID Clinical Phenotypes Through Cluster Analysis of Self-Reported Symptoms. Open Forum Infect Dis 2022;9:ofac060. 10.1093/ofid/ofac060&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac060</ArticleId><ArticleId IdType="pmc">PMC8900926</ArticleId><ArticleId IdType="pubmed">35265728</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlisle JB. False individual patient data and zombie randomised controlled trials submitted to Anaesthesia. Anaesthesia 2021;76:472-9. 10.1111/anae.15263&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15263</ArticleId><ArticleId IdType="pubmed">33040331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis JPA. Hundreds of thousands of zombie randomised trials circulate among us. Anaesthesia 2021;76:444-7. 10.1111/anae.15297&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15297</ArticleId><ArticleId IdType="pubmed">33124075</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol BW, Lai S, Rahim A, et al. . Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot. Res Integr Peer Rev 2023;8:6. 10.1186/s41073-023-00130-8&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41073-023-00130-8</ArticleId><ArticleId IdType="pmc">PMC10280869</ArticleId><ArticleId IdType="pubmed">37337220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JAC, Savovi&#x107; J, Page MJ, et al. . RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898. 10.1136/bmj.l4898&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l4898</ArticleId><ArticleId IdType="pubmed">31462531</ArticleId></ArticleIdList></Reference><Reference><Citation>Pitre T, Kirsh S, Jassal T, et al. . The impact of blinding on trial results: A systematic review and meta-analysis. Cochrane Evidence Synthesis and Methods 2023;1:e12015 10.1002/cesm.12015 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cesm.12015</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeraatkar D, Pitre T, Diaz-Martinez JP, et al. . Impact of Allocation Concealment and Blinding in Trials Addressing Treatments for COVID-19: A Methods Study. Am J Epidemiol 2023;192:1678-87. 10.1093/aje/kwad131&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwad131</ArticleId><ArticleId IdType="pmc">PMC10558187</ArticleId><ArticleId IdType="pubmed">37254775</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghirad B, Foroutan F, Zoratti MJ, et al. . Theory and practice of Bayesian and frequentist frameworks for network meta-analysis. BMJ Evid Based Med 2023;28:204-09. 10.1136/bmjebm-2022-111928&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjebm-2022-111928</ArticleId><ArticleId IdType="pubmed">35760451</ArticleId></ArticleIdList></Reference><Reference><Citation>Langan D, Higgins JPT, Jackson D, et al. . A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses. Res Synth Methods 2019;10:83-98. 10.1002/jrsm.1316&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.1316</ArticleId><ArticleId IdType="pubmed">30067315</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JPT, Thomas J, Chandler J, et al, eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. www.training.cochrane.org/handbook.</Citation></Reference><Reference><Citation>Johnston BC, Patrick DL, Thorlund K, et al. . Patient-reported outcomes in meta-analyses-part 2: methods for improving interpretability for decision-makers. Health Qual Life Outcomes 2013;11:211. 10.1186/1477-7525-11-211&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1477-7525-11-211</ArticleId><ArticleId IdType="pmc">PMC3984637</ArticleId><ArticleId IdType="pubmed">24359184</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlund K, Walter SD, Johnston BC, Furukawa TA, Guyatt GH. Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability. Res Synth Methods 2011;2:188-203. 10.1002/jrsm.46&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.46</ArticleId><ArticleId IdType="pubmed">26061786</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller KF, Meerpohl JJ, Briel M, et al. . Methods for detecting, quantifying, and adjusting for dissemination bias&#xa0;in meta-analysis are described. J Clin Epidemiol 2016;80:25-33. 10.1016/j.jclinepi.2016.04.015&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2016.04.015</ArticleId><ArticleId IdType="pubmed">27502970</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Sutton AJ, Ioannidis JP, et al. . Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002. 10.1136/bmj.d4002&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.d4002</ArticleId><ArticleId IdType="pubmed">21784880</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt G, Oxman AD, Akl EA, et al. . GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 2011;64:383-94. 10.1016/j.jclinepi.2010.04.026&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2010.04.026</ArticleId><ArticleId IdType="pubmed">21195583</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Kulzhabayeva D, Rodrigues NB, et al. . COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysis. Brain Behav Immun 2023;111:211-29. 10.1016/j.bbi.2023.03.022&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10067136</ArticleId><ArticleId IdType="pubmed">36990297</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. 10.1136/bmj.39489.470347.AD&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.39489.470347.AD</ArticleId><ArticleId IdType="pmc">PMC2335261</ArticleId><ArticleId IdType="pubmed">18436948</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L, Brignardello-Petersen R, Hultcrantz M, et al. . GRADE Guidance 34: update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol 2022;150:216-24. 10.1016/j.jclinepi.2022.07.014&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2022.07.014</ArticleId><ArticleId IdType="pubmed">35934265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;nemann HJ, Neumann I, Hultcrantz M, et al. GRADE Working Group . GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions. J Clin Epidemiol 2022;150:225-42. 10.1016/j.jclinepi.2022.07.015&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2022.07.015</ArticleId><ArticleId IdType="pubmed">35934266</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann I, Qui&#xf1;elen E, Nahuelhual P, et al. . Using Explicit Thresholds were valuable for judging Benefits and Harms in partially contextualized GRADE Guidelines. J Clin Epidemiol 2022;147:69-75. 10.1016/j.jclinepi.2022.03.017&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2022.03.017</ArticleId><ArticleId IdType="pmc">PMC8963975</ArticleId><ArticleId IdType="pubmed">35364230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mouelhi Y, Jouve E, Castelli C, Gentile S. How is the minimal clinically important difference established in health-related quality of life instruments? Review of anchors and methods. Health Qual Life Outcomes 2020;18:136. 10.1186/s12955-020-01344-w&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-020-01344-w</ArticleId><ArticleId IdType="pmc">PMC7218583</ArticleId><ArticleId IdType="pubmed">32398083</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazendam AM, Schneider P, Bhandari M, Busse JW, Ghert M, on behalf of the PARITY Investigators . Defining Minimally Important Differences in Functional Outcomes in Musculoskeletal Oncology. J Bone Joint Surg Am 2022;104:1659-66. 10.2106/JBJS.21.01539&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.2106/JBJS.21.01539</ArticleId><ArticleId IdType="pubmed">35809001</ArticleId></ArticleIdList></Reference><Reference><Citation>Devji T, Carrasco-Labra A, Guyatt G. Mind the methods of determining minimal important differences: three critical issues to consider. Evid Based Ment Health 2021;24:77-81. 10.1136/ebmental-2020-300164&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2020-300164</ArticleId><ArticleId IdType="pmc">PMC10231500</ArticleId><ArticleId IdType="pubmed">32839275</ArticleId></ArticleIdList></Reference><Reference><Citation>Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol 1994;47:81-7. 10.1016/0895-4356(94)90036-1&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(94)90036-1</ArticleId><ArticleId IdType="pubmed">8283197</ArticleId></ArticleIdList></Reference><Reference><Citation>Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-92. 10.1097/01.MLR.0000062554.74615.4C&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MLR.0000062554.74615.4C</ArticleId><ArticleId IdType="pubmed">12719681</ArticleId></ArticleIdList></Reference><Reference><Citation>Devji T, Carrasco-Labra A, Qasim A, et al. . Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study. BMJ 2020;369:m1714. 10.1136/bmj.m1714&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1714</ArticleId><ArticleId IdType="pmc">PMC7270853</ArticleId><ArticleId IdType="pubmed">32499297</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, McKenzie JE, Bossuyt PM, et al. . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71. 10.1136/bmj.n71&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n71</ArticleId><ArticleId IdType="pmc">PMC8005924</ArticleId><ArticleId IdType="pubmed">33782057</ArticleId></ArticleIdList></Reference><Reference><Citation>Santesso N, Glenton C, Dahm P, et al. GRADE Working Group . GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions. J Clin Epidemiol 2020;119:126-35. 10.1016/j.jclinepi.2019.10.014&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2019.10.014</ArticleId><ArticleId IdType="pubmed">31711912</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaylis NB, Ritter A, Kelly SA, et al. . Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome. Clin Infect Dis 2022;75:1232-4. 10.1093/cid/ciac226&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac226</ArticleId><ArticleId IdType="pmc">PMC9383814</ArticleId><ArticleId IdType="pubmed">35452519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kutashov VA. Actovegin use in patients with cognitive impairment after coronavirus infection (COVID-19). Neurology, Neuropsychiatry. Psychosomatics 2021;13:65-72.</Citation></Reference><Reference><Citation>McIntyre RS, Phan L, Kwan ATH, et al. . Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial. Brain 2024;147:849-57. 10.1093/brain/awad377&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad377</ArticleId><ArticleId IdType="pubmed">37936330</ArticleId></ArticleIdList></Reference><Reference><Citation>Sizyakina LP, Zakurskaya VY, Guryanova SV. Glucosaminylmuramyl dipeptide efficacy in post-COVID-19 patient rehabilitation treatment. Infectious diseases: News, Opinions. Training 2023;12:17-25.</Citation></Reference><Reference><Citation>Ali AA, Elnahas NG, Algazzar SA, Lotfy AWM, Taha EM. Impact Of Active Cycle Of Breathing Technique On Selected Pulmonary Outcomes In Post-COVID Syndrome Patients. J Pharm Negat Results 2023;14:710-7. .</Citation></Reference><Reference><Citation>McNarry MA, Berg RMG, Shelley J, et al. . Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial. Eur Respir J 2022;60:2103101. 10.1183/13993003.03101-2021&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03101-2021</ArticleId><ArticleId IdType="pmc">PMC8900538</ArticleId><ArticleId IdType="pubmed">35236727</ArticleId></ArticleIdList></Reference><Reference><Citation>Mooren JM, Garbsch R, Sch&#xe4;fer H, et al. . Medical Rehabilitation of Patients with Post-COVID-19 Syndrome-A Comparison of Aerobic Interval and Continuous Training. J Clin Med 2023;12:6739. 10.3390/jcm12216739&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12216739</ArticleId><ArticleId IdType="pmc">PMC10649998</ArticleId><ArticleId IdType="pubmed">37959205</ArticleId></ArticleIdList></Reference><Reference><Citation>Nambi GA-O, Abdelbasset WA-OX, Alrawaili SM, et al. . Comparative effectiveness study of low versus high-intensity aerobic training with resistance training in community-dwelling older men with post-COVID 19 sarcopenia: A randomized controlled trial. Clin Rehabil 2022;36:59-68. 10.1177/02692155211036956&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/02692155211036956</ArticleId><ArticleId IdType="pubmed">34344230</ArticleId></ArticleIdList></Reference><Reference><Citation>Omarova I, Akanova A, Kurmanova A, et al. . Acupuncture as an Additional Method of Rehabilitation Post-COVID-19: a randomized controlled trial. J Pharmacopuncture 2023;26:238-46. 10.3831/KPI.2023.26.3.238&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3831/KPI.2023.26.3.238</ArticleId><ArticleId IdType="pmc">PMC10547817</ArticleId><ArticleId IdType="pubmed">37799621</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanet C, Wormser J, Fels A, et al. . Effectiveness of exercise training on the dyspnoea of individuals with long COVID: A randomised controlled multicentre trial. Ann Phys Rehabil Med 2023;66:101765. 10.1016/j.rehab.2023.101765&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rehab.2023.101765</ArticleId><ArticleId IdType="pmc">PMC10237688</ArticleId><ArticleId IdType="pubmed">37271020</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira KCV, de Lima Ferreira AP, de Andrade Silva D, et al. . The impact of post-COVID multicomponent rehabilitation. Fisioter Mov 2023;36:e36112.</Citation></Reference><Reference><Citation>Pleguezuelos E, Del Carmen A, Moreno E, Miravitlles M, Serra M, Garnacho-Casta&#xf1;o MV. Effects of a telerehabilitation program and detraining on cardiorespiratory fitness in patients with post-COVID-19 sequelae: A randomized controlled trial. Scand J Med Sci Sports 2024;34:e14543. 10.1111/sms.14543&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sms.14543</ArticleId><ArticleId IdType="pubmed">38009852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuut TA, M&#xfc;ller F, Csorba I, et al. . Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019: Results of a Randomized Controlled Trial. Clin Infect Dis 2023;77:687-95. 10.1093/cid/ciad257&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciad257</ArticleId><ArticleId IdType="pmc">PMC10495128</ArticleId><ArticleId IdType="pubmed">37155736</ArticleId></ArticleIdList></Reference><Reference><Citation>Samper-Pardo M, Le&#xf3;n-Herrera S, Oliv&#xe1;n-Bl&#xe1;zquez B, M&#xe9;ndez-L&#xf3;pez F, Dom&#xed;nguez-Garc&#xed;a M, S&#xe1;nchez-Recio R. Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a randomized, 3-month follow-up clinical trial. Sci Rep 2023;13:7943. 10.1038/s41598-023-35058-y&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-35058-y</ArticleId><ArticleId IdType="pmc">PMC10187508</ArticleId><ArticleId IdType="pubmed">37193738</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint LL, Bratty AJ. Amygdala and Insula Retraining (AIR) Significantly Reduces Fatigue and Increases Energy in People with Long COVID. Evid Based Complement Alternat Med 2023;2023:7068326. 10.1155/2023/7068326&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/7068326</ArticleId><ArticleId IdType="pmc">PMC10365910</ArticleId><ArticleId IdType="pubmed">37492483</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau RI, Su Q, Lau ISF, et al. . A synbiotic preparation (SIM01) for post-acute COVID-19 syndrome in Hong Kong (RECOVERY): a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2024;24:256-65. 10.1016/S1473-3099(23)00685-0&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00685-0</ArticleId><ArticleId IdType="pubmed">38071990</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanashyan MM, Raskurazhev AA, Kuznetsova PI, Bely PA, Zaslavskaya KI. [Prospects and possibilities for the treatment of patients with long COVID-19 syndrome]. Ter Arkh 2022;94:1285-93. 10.26442/00403660.2022.11.201981&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.26442/00403660.2022.11.201981</ArticleId><ArticleId IdType="pubmed">37167167</ArticleId></ArticleIdList></Reference><Reference><Citation>Tosato M, Calvani R, Picca A, et al. Gemelli against COVID-19 Post-Acute Care Team . Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial. Nutrients 2022;14:4984. 10.3390/nu14234984&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14234984</ArticleId><ArticleId IdType="pmc">PMC9738241</ArticleId><ArticleId IdType="pubmed">36501014</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbannaa R, Mogahed H, Zahran M, Mohamed E. The effect of photobiomodulation versus placebo on functional capacity and fatigability in post COVID-19 elderly. Advances in Rehabilitation 2022;36:19-25 10.5114/areh.2022.119900 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/areh.2022.119900</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana K, Fran&#xe7;a E, Sato J, et al. . Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC). Brain Stimul 2023;16:100-7. 10.1016/j.brs.2023.01.1672&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2023.01.1672</ArticleId><ArticleId IdType="pmc">PMC9867562</ArticleId><ArticleId IdType="pubmed">36693536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S, Catalogna M, Sasson E, et al. . Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial. Sci Rep 2022;12:11252. 10.1038/s41598-022-15565-0&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabokon AM, Zakharova NV, Indeikina MI, et al. . Changes in the proteomics of exhaled breath condensate under the influence of inhaled hydrogen in patients with post-COVID syndrome. Cardiovasc Ther Prev (Fidenza) 2023;22 10.15829/1728-8800-2023-3517 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15829/1728-8800-2023-3517</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor G, Sandhu H, Bruce J, et al. . Clinical effectiveness of an online supervised group physical and mental health rehabilitation programme for adults with post-covid-19 condition (REGAIN study): multicentre randomised controlled trial. BMJ 2024;384:e076506. 10.1136/bmj-2023-076506&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2023-076506</ArticleId><ArticleId IdType="pmc">PMC11134408</ArticleId><ArticleId IdType="pubmed">38325873</ArticleId></ArticleIdList></Reference><Reference><Citation>Samper-Pardo M, Oliv&#xe1;n-Bl&#xe1;zquez B, Le&#xf3;n-Herrera S, S&#xe1;nchez-Arizcuren R, Casado-Vicente V, S&#xe1;nchez-Recio R. Effectiveness of ReCOVery APP to improve the quality of life of Long COVID patients: a 6-month follow-up randomized clinical trial. Mental Health Weekly Digest 2023;136. link.gale.com/apps/doc/A765622543/HRCA?u=anon~9bd9e49&amp;sid=sitemap&amp;xid=13de2635
10.1101/2023.08.30.23294831 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.08.30.23294831</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson JM, Saag MS, Thompson MA, et al. . Antiviral activity of single-dose PRO 140, a CCR5 monoclonal antibody, in HIV-infected adults. J Infect Dis 2008;198:1345-52. 10.1086/592169&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/592169</ArticleId><ArticleId IdType="pubmed">18771406</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson BK, Seethamraju H, Dhody K, et al. . CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int J Infect Dis 2021;103:25-32. 10.1016/j.ijid.2020.10.101&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.101</ArticleId><ArticleId IdType="pmc">PMC7654230</ArticleId><ArticleId IdType="pubmed">33186704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandieh S, Abdollahzadeh SM, Sadeghirad B, et al. . Therapist-guided remote versus in-person cognitive behavioural therapy: a systematic review and meta-analysis of randomized controlled trials. CMAJ 2024;196:E327-40. 10.1503/cmaj.230274.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.230274</ArticleId><ArticleId IdType="pmc">PMC10948182</ArticleId><ArticleId IdType="pubmed">38499303</ArticleId></ArticleIdList></Reference><Reference><Citation>
Zhang RC, Ladyzhets B. The NIH has poured $1 billion into long Covid research &#x2014; with little to show for it. Stat
2023. https://www.statnews.com/2023/04/20/long-covid-nih-billion/.</Citation></Reference><Reference><Citation>Blair SN, Morris JN. Healthy hearts--and the universal benefits of being physically active: physical activity and health. Ann Epidemiol 2009;19:253-6. 10.1016/j.annepidem.2009.01.019&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2009.01.019</ArticleId><ArticleId IdType="pubmed">19344864</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott AJ, Bisby MA, Heriseanu AI, et al. . Cognitive behavioral therapies for depression and anxiety in people with chronic disease: A systematic review and meta-analysis. Clin Psychol Rev 2023;106:102353. 10.1016/j.cpr.2023.102353&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2023.102353</ArticleId><ArticleId IdType="pubmed">37865080</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpstra JA, van der Vaart R, van Beugen S, et al. . Guided internet-based cognitive-behavioral therapy for patients with chronic pain: A meta-analytic review. Internet Interv 2022;30:100587. 10.1016/j.invent.2022.100587&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.invent.2022.100587</ArticleId><ArticleId IdType="pmc">PMC9672957</ArticleId><ArticleId IdType="pubmed">36406977</ArticleId></ArticleIdList></Reference><Reference><Citation>Gielissen MF, Verhagen CA, Bleijenberg G. Cognitive behaviour therapy for fatigued cancer survivors: long-term follow-up. Br J Cancer 2007;97:612-8. 10.1038/sj.bjc.6603899&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.bjc.6603899</ArticleId><ArticleId IdType="pmc">PMC2360364</ArticleId><ArticleId IdType="pubmed">17653075</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne) 2023;10:1187163. 10.3389/fmed.2023.1187163&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev 2019;10:CD003200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6953363</ArticleId><ArticleId IdType="pubmed">31577366</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DY, Lee JS, Park SY, Kim SJ, Son CG. Systematic review of randomized controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med 2020;18:7. 10.1186/s12967-019-02196-9&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-02196-9</ArticleId><ArticleId IdType="pmc">PMC6943902</ArticleId><ArticleId IdType="pubmed">31906979</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharpe M, Chalder T, White PD. Evidence-Based Care for People with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis. J Gen Intern Med 2022;37:449-52. 10.1007/s11606-021-07188-4&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07188-4</ArticleId><ArticleId IdType="pmc">PMC8811058</ArticleId><ArticleId IdType="pubmed">34791590</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulme K, Hudson JL, Rojczyk P, Little P, Moss-Morris R. Biopsychosocial risk factors of persistent fatigue after acute infection: A systematic review to inform interventions. J Psychosom Res 2017;99:120-9. 10.1016/j.jpsychores.2017.06.013&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2017.06.013</ArticleId><ArticleId IdType="pubmed">28712416</ArticleId></ArticleIdList></Reference><Reference><Citation>Vink M, Vink-Niese F. Graded exercise therapy does not restore the ability to work in ME/CFS - Rethinking of a Cochrane review. Work 2020;66:283-308. 10.3233/WOR-203174&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-203174</ArticleId><ArticleId IdType="pubmed">32568149</ArticleId></ArticleIdList></Reference><Reference><Citation>Twisk FN, Maes M. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS. Neuro Endocrinol Lett 2009;30:284-99.</Citation><ArticleIdList><ArticleId IdType="pubmed">19855350</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Mak JWY, Su Q, et al. . Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 2022;71:544-52. 10.1136/gutjnl-2021-325989&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilg H, Zmora N, Adolph TE, Elinav E. The intestinal microbiota fuelling metabolic inflammation. Nat Rev Immunol 2020;20:40-54. 10.1038/s41577-019-0198-4&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0198-4</ArticleId><ArticleId IdType="pubmed">31388093</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh YK, Zuo T, Lui GC, et al. . Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 2021;70:698-706. 10.1136/gutjnl-2020-323020&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wan Y, Zuo T, et al. . Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19. Gastroenterology 2022;162:548-561.e4. 10.1053/j.gastro.2021.10.013&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T, Zhang F, Lui GCY, et al. . Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology 2020;159:944-955.e8. 10.1053/j.gastro.2020.05.048&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.05.048</ArticleId><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff A, Kavanaugh M, Ramgobin D, et al. . Gastrointestinal Manifestations of COVID-19: A Review of What We Know. Ochsner J 2021;21:177-80. 10.31486/toj.20.0086&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.31486/toj.20.0086</ArticleId><ArticleId IdType="pmc">PMC8238098</ArticleId><ArticleId IdType="pubmed">34239378</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf8;kke FB, Hansen KS, Dalgaard LS, &#xd6;brink-Hansen K, Schi&#xf8;ttz-Christensen B, Leth S. Long-term complications after infection with SARS-CoV-1, influenza and MERS-CoV - Lessons to learn in long COVID? Infect Dis Now 2023;53:104779. 10.1016/j.idnow.2023.104779&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2023.104779</ArticleId><ArticleId IdType="pubmed">37678512</ArticleId></ArticleIdList></Reference><Reference><Citation>Murad MH, Mustafa R, Morgan R, Sultan S, Falck-Ytter Y, Dahm P. Rating the quality of evidence is by necessity a matter of judgment. J Clin Epidemiol 2016;74:237-8. 10.1016/j.jclinepi.2015.11.018&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2015.11.018</ArticleId><ArticleId IdType="pubmed">26772606</ArticleId></ArticleIdList></Reference><Reference><Citation>Basch E. The missing voice of patients in drug-safety reporting. N Engl J Med 2010;362:865-9. 10.1056/NEJMp0911494&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp0911494</ArticleId><ArticleId IdType="pmc">PMC3031980</ArticleId><ArticleId IdType="pubmed">20220181</ArticleId></ArticleIdList></Reference><Reference><Citation>Weldring T, Smith SM. Patient-Reported Outcomes (PROs) and Patient-Reported Outcome Measures (PROMs). Health Serv Insights 2013;6:61-8. 10.4137/HSI.S11093&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.4137/HSI.S11093</ArticleId><ArticleId IdType="pmc">PMC4089835</ArticleId><ArticleId IdType="pubmed">25114561</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercieca-Bebber R, King MT, Calvert MJ, Stockler MR, Friedlander M. The importance of patient-reported outcomes in clinical trials and strategies for future optimization. Patient Relat Outcome Meas 2018;9:353-67. 10.2147/PROM.S156279&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/PROM.S156279</ArticleId><ArticleId IdType="pmc">PMC6219423</ArticleId><ArticleId IdType="pubmed">30464666</ArticleId></ArticleIdList></Reference><Reference><Citation>Hohenschurz-Schmidt D, Vase L, Scott W, et al. . Recommendations for the development, implementation, and reporting of control interventions in efficacy and mechanistic trials of physical, psychological, and self-management therapies: the CoPPS Statement. BMJ 2023;381:e072108. 10.1136/bmj-2022-072108.&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072108</ArticleId><ArticleId IdType="pubmed">37230508</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, Goldsmith KA, Johnson AL, et al. PACE trial management group . Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet 2011;377:823-36. 10.1016/S0140-6736(11)60096-2&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60096-2</ArticleId><ArticleId IdType="pmc">PMC3065633</ArticleId><ArticleId IdType="pubmed">21334061</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Moschopoulos CD, Margalit I, et al. . ESCMID rapid guidelines for assessment and management of long COVID. Clin Microbiol Infect 2022;28:955-72. 10.1016/j.cmi.2022.02.018&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.02.018</ArticleId><ArticleId IdType="pmc">PMC8849856</ArticleId><ArticleId IdType="pubmed">35182760</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. 2020. https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Nurek M, Rayner C, Freyer A, et al. Delphi panellists . Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract 2021;71:e815-25. 10.3399/BJGP.2021.0265&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0265</ArticleId><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Sivan M, Perlowski A, Nikolich J&#x17d;. Long COVID: a clinical update. Lancet 2024;404:707-24. 10.1016/S0140-6736(24)01136-X&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01136-X</ArticleId><ArticleId IdType="pubmed">39096925</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Clinical management of COVID-19: Living guideline, 18 August 2023. 2023. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2023.2.</Citation><ArticleIdList><ArticleId IdType="pubmed">35917394</ArticleId></ArticleIdList></Reference><Reference><Citation>Tryfonos A, Pourhamidi K, J&#xf6;rn&#xe5;ker G, et al. . Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition: A Randomized Crossover Clinical Trial. JAMA Netw Open 2024;7:e244386. 10.1001/jamanetworkopen.2024.4386&#xa0;</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2024.4386</ArticleId><ArticleId IdType="pmc">PMC11192186</ArticleId><ArticleId IdType="pubmed">38573638</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>